Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

BG Group Appoints Simon Lowth As CFO - Quick Facts

7/15/2013 2:14 AM ET

BG Group Plc. (BRGYY.PK,BG.L) announced Monday that it has appointed Simon Lowth as its Chief Financial Officer and as an Executive Director, effective from November 2013. Simon will succeed Den Jones who has been Interim Chief Financial Officer and Executive Director since February 2013.

The company noted that the effective date of the appointments remains to be confirmed and will be the subject of a separate announcement.

Simon is currently the Chief Financial Officer of AstraZeneca Plc. (AZN: Quote,AZN.L) and an Executive Director on its Board. He joined the biopharmaceutical company in November 2007 and is responsible for Finance, Investor Relations, and AstraZeneca's business in Japan.

Simon has been a non-executive director of Standard Chartered PLC since 2010.

Before joining to AstraZeneca, Simon served at Scottish Power PLC from 2003 to 2007. In 2005, Simon was appointed Finance Director, successfully leading a drive to improve both earnings and cash generation. Simon previously spent 15 years working for McKinsey & Company, latterly as the Director responsible for the UK industrial practice.

Click here to receive FREE breaking news email alerts for BG Group plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks are turning in a lackluster performance in morning trading on Monday after showing a strong move to the upside last week. The major averages have been unable to sustain any significant moves, bouncing back and forth across the unchanged line. Leading U.S. economic indicators showed continued improvement in the month of March, according to a report released by the Conference Board on Monday, with the leading economic index rising by slightly more than expected. The Conference Board said its leading economic index rose by 0.8 percent in March after climbing by 0.5 percent in February. Healthcare products maker Kimberly-Clark Corp. (KMB) said that its first-quarter net income attributable to the company rose to $538 million from the prior year's $531 million, with earnings per share improving to $1.41 from $1.36 last year. Adjusted earnings for the quarter were $1.48 per share,...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.